Hexagon Nutrition, a prominent nutrition company, is set to launch its Initial Public Offering (IPO) on Friday, June 5, 2026. The anchor book for the issue will open a day earlier, on Thursday, June 4, 2026, with the bidding concluding on Tuesday, June 9, 2026.
The IPO features equity shares with a face value of Re 1 each, offered within a price band of Rs 42 to Rs 45 per share. Investors can bid for a minimum of 333 equity shares, and thereafter in multiples of that amount.
Issue Details and Shareholder Offer
The Hexagon Nutrition IPO consists entirely of an offer for sale (OFS) of up to 30,859,704 equity shares by existing shareholders. At the upper end of the price band, this aggregates to approximately Rs 1,388.69 million, or Rs 138.87 crore.
The selling shareholders include promoters Arun Purushottam Kelkar, Subhash Purushottam Kelkar, Aditya Kelkar, and Nutan Subhash Kelkar. Cumulative Capital and Catalyst Capital Partners have been appointed as the book-running lead managers for the issue.
About Hexagon Nutrition
Hexagon Nutrition operates across the entire nutrition value chain. The company offers a diverse portfolio including branded wellness nutrition and clinical nutrition products in the business-to-consumer (B2C) segment. It also provides premix formulations for the business-to-business-to-consumer (B2B2C) segment, alongside ready-to-use foods and micronutrient powders in the ESG (Environmental, Social, and Governance) segment.
The company boasts a significant international footprint, working through 19 non-exclusive regional distributors across Latin America, Southeast Asia, Africa, and the Middle East. Hexagon Nutrition also maintains three overseas offices located in South Africa, Uzbekistan, and Hong Kong. Over the last three fiscal years, its products have been exported to more than 75 countries globally.
Investor Allocation and Listing
The IPO allocation structure reserves not more than 50 percent of the offer for qualified institutional buyers (QIBs). Within this QIB portion, up to 60 percent will be available for anchor investors. Retail investors are allocated 35 percent of the shares, while high net-worth individual (HNI) investors will receive 15 percent of the shares reserved in the IPO.
The equity shares of Hexagon Nutrition are proposed to be listed on both the BSE and the National Stock Exchange (NSE), with NSE designated as the primary stock exchange for listing.